Prospective study of the value of transbronchial lung biopsy after lung transplantation

Transbronchial lung biopsy (TBB) has become the gold standard for the diagnosis of acute rejection and cytomegalovirus (CMV) pneumonia in lung transplant recipients. The aim of this study was to assess the value of regular surveillance TBB in stable asymptomatic patients and to establish the role of TBB as a follow-up procedure 1 month after a previous pathological biopsy result. We prospectively evaluated 76 TBBs performed in 17 lung transplant recipients. A definite pathological results was found in 14 of 15 TBBs performed for clinical indications: CMV pneumonia (5), acute rejection grade > or = A2 according to the criteria of the International Society for Heart and Lung Transplantation (ISHLT) (4), bronchiolitis obliterans (3), and desquamative interstitial pneumonitis (2). Fifteen of 45 surveillance TBBs performed in asymptomatic patients revealed significant abnormalities. Ten episodes of acute rejection ISHLT grade > or = A2 and three episodes of CMV pneumonia detected by TBB had direct therapeutic consequences. Nine of 16 follow-up TBBs performed 1 month after a pathological biopsy result again showed relevant pathological findings. With the exception of one severe haemorrhage, no life-threatening complications occurred. Our results suggest that transbronchial lung biopsies performed on a regular basis after lung transplantation are important for the detection of asymptomatic and/or persistent acute rejection or injection. In the long-term, this strategy might be the most effective tool in reducing the incidence of bronchiolitis obliterans, which is still the main obstacle for further improvement of long-term survival after lung transplantation.

This article has been cited by other articles:

				C. L. Greene, B. Reemtsen, A. Polimenakos, M. Horn, and W. Wells Role of clinically indicated transbronchial lung biopsies in the management of pediatric post-lung transplant patients. Ann. Thorac. Surg., July 1, 2008; 86(1): 198 - 203. [Abstract] [Full Text] [PDF]

				M. S. Krishnam, R. D. Suh, A. Tomasian, J. G. Goldin, C. Lai, K. Brown, P. Batra, and D. R. Aberle Postoperative Complications of Lung Transplantation: Radiologic Findings along a Time Continuum RadioGraphics, July 1, 2007; 27(4): 957 - 974. [Abstract] [Full Text] [PDF]

				C Benden, O Harpur-Sinclair, A S Ranasinghe, J C Hartley, M J Elliott, and P Aurora Surveillance bronchoscopy in children during the first year after lung transplantation: is it worth it? Thorax, January 1, 2007; 62(1): 57 - 61. [Abstract] [Full Text] [PDF]

				B. M. Vanaudenaerde, L. J. Dupont, W. A. Wuyts, E. K. Verbeken, I. Meyts, D. M. Bullens, E. Dilissen, L. Luyts, D. E. Van Raemdonck, and G. M. Verleden The role of interleukin-17 during acute rejection after lung transplantation. Eur. Respir. J., April 1, 2006; 27(4): 779 - 787. [Abstract] [Full Text] [PDF]

				P. Sandmeier, R. Speich, E. Grebski, P. Vogt, E. W. Russi, W. Weder, and A. Boehler Iron Accumulation in Lung Allografts Is Associated With Acute Rejection But Not With Adverse Outcome Chest, September 1, 2005; 128(3): 1379 - 1384. [Abstract] [Full Text] [PDF]

				G. A. Visner, A. Faro, and D. S. Zander Role of Transbronchial Biopsies in Pediatric Lung Diseases Chest, July 1, 2004; 126(1): 273 - 280. [Abstract] [Full Text] [PDF]

				C. L. Lau, G. A. Patterson, and S. M. Palmer Critical Care Aspects of Lung Transplantation J Intensive Care Med, March 1, 2004; 19(2): 83 - 104. [Abstract] [PDF]

				C. Knoop, A. Haverich, and S. Fischer Immunosuppressive therapy after human lung transplantation Eur. Respir. J., January 1, 2004; 23(1): 159 - 171. [Abstract] [Full Text] [PDF]

				A. Boehler and M. Estenne Post-transplant bronchiolitis obliterans Eur. Respir. J., December 1, 2003; 22(6): 1007 - 1018. [Abstract] [Full Text] [PDF]

				C.L. Lau and G.A. Patterson Current status of lung transplantation Eur. Respir. J., November 16, 2003; 22(47_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]

				M. Estenne and M. I. Hertz Bronchiolitis Obliterans after Human Lung Transplantation Am. J. Respir. Crit. Care Med., August 15, 2002; 166(4): 440 - 444. [Full Text] [PDF]

				M. Reynaud-Gaubert, P. Thomas, R. Gregoire, M. Badier, P. Cau, J. Sampol, R. Giudicelli, and P. Fuentes Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 60 - 66. [Abstract] [Full Text] [PDF]

				S. J. Swanson, S. J. Mentzer, J. J. Reilly, R. Bueno, J. M. Lukanich, M. T. Jaklitsch, L. Kobzik, E. P. Ingenito, A. Fuhlbrigge, C. Donovan, et al. SURVEILLANCE TRANSBRONCHIAL LUNG BIOPSIES: IMPLICATION FOR SURVIVAL AFTER LUNG TRANSPLANTATION J. Thorac. Cardiovasc. Surg., January 1, 2000; 119(1): 27 - 38. [Abstract] [Full Text] [PDF]

				J. A. Henke, J. A. Golden, E. H. Yelin, F. A. Keith, and P. D. Blanc Persistent Increases of BAL Neutrophils as a Predictor of Mortality Following Lung Transplant Chest, February 1, 1999; 115(2): 403 - 409. [Abstract] [Full Text] [PDF]

				L. L. SCHULMAN, A. D. WEINBERG, C. MCGREGOR, M. E. GALANTOWICZ, N. M. SUCIU-FOCA, and S. ITESCU Mismatches at the HLA-DR and HLA-B Loci Are Risk Factors for Acute Rejection after Lung Transplantation Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1833 - 1837. [Abstract] [Full Text] [PDF]